SIC
HUMA icon

SJS Investment Consulting’s Humacyte HUMA Stock Holding History

SJS Investment Consulting’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$367 Buy
469
+379
+421% +$351 ﹤0.01% 2351
2026
Q1 		$55 Buy
+90
New +$94 ﹤0.01% 2239

Other funds holding HUMA

PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
UAS
United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CWA
Clarus Wealth Advisors Peoria, Arizona $260M AUM 27.97% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
VMMC
V.M. Manning & Co Greenville, South Carolina $117M AUM

SJS Investment Consulting's HUMA Position: Q2 2026 in Review

SJS Investment Consulting increased its Humacyte (HUMA) stake by 421% in Q2 2026, buying an estimated $351 and bringing the position to 469 shares worth $367. The position accounts for ﹤0.01% of the portfolio, ranked #2351.

SJS Investment Consulting first reported a position in HUMA in Q1 2026 and has held it in 2 quarters since. 40 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • SJS Investment Consulting held 469 shares of Humacyte worth $367 as of Q2 2026.
  • SJS Investment Consulting bought 379 Humacyte shares in Q2 2026, an estimated $351.
  • Humacyte made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2351 holding.
  • SJS Investment Consulting first reported a position in Humacyte in Q1 2026 and has held it in 2 quarters since.
  • 40 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.